Adverse effects: 1. Sedation · patients with schizophrenia
1 finding from 1 review
Adverse effects: 1. Sedation · patients with schizophrenia
1 finding from 1 review
Adverse effects: 1. Sedation · schizophrenia
QUETIAPINE probably leads to lower adverse effects: 1. Sedation compared with CLOZAPINE ‐ all data short term (moderate certainty).
1 finding from 1 review
Adverse effects: 1. Sedation · schizophrenia
QUETIAPINE showed no clear difference in adverse effects: 1. Sedation compared with OLANZAPINE (moderate certainty).
1 finding from 1 review
Adverse effects: 1. Sedation · schizophrenia
1 finding from 1 review
Adverse effects: 1. Sedation · schizophrenia
QUETIAPINE led to higher adverse effects: 1. Sedation compared with RISPERIDONE; GRADE not reported.
1 finding from 1 review
Adverse effects: 1. Sedation · schizophrenia
QUETIAPINE may leads to higher adverse effects: 1. Sedation compared with ZIPRASIDONE (low certainty).
1 finding from 1 review
Adverse effects: 1. Sedation · schizophrenia
1 finding from 1 review
Sedation and somnolence (secondary outcome 2) · participants with acute pancreatitis pain
Opioids showed no clear difference in sedation and somnolence (secondary outcome 2) compared with no opioids (low certainty).
1 finding from 1 review
Sedation/tranquillisation: Not sedated ‐ at four hours · patients with acute schizophrenia and similar serious mental illnesses
ZUCLOPENTHIXOL ACETATE showed no clear difference in sedation/tranquillisation: Not sedated ‐ at four hours compared with STANDARD DRUG CARE (low certainty).
1 finding from 1 review
Sedation/tranquillisation: Not sedated ‐ at four hours · patients with acute schizophrenia and similar serious mental illnesses
1 finding from 1 review
Desired sedation ‐ ultra short term ‐ asleep at 12 hours · patients with schizophrenia
BENZODIAZEPINES showed no clear difference in desired sedation ‐ ultra short term ‐ asleep at 12 hours compared with ANTIPSYCHOTICS (low certainty).
1 finding from 1 review
Desired sedation ‐ ultra short term ‐ tranquillised at 60 minutes · patients with schizophrenia
ADJUNCTIVE BENZODIAZEPINES + ANTIPSYCHOTICS may leads to higher desired sedation ‐ ultra short term ‐ tranquillised at 60 minutes compared with PLACEBO/NO ADJUNCTIVE TREATMENT + ANTIPSYCHOTICS (low certainty).
1 finding from 1 review
Desired sedation ‐ ultra short term ‐ asleep at 12 hours · patients with schizophrenia
ADJUNCTIVE BENZODIAZEPINES + ANTIPSYCHOTICS showed no clear difference in desired sedation ‐ ultra short term ‐ asleep at 12 hours compared with PLACEBO/NO ADJUNCTIVE TREATMENT + ANTIPSYCHOTICS (low certainty).
1 finding from 1 review
Number of participants tranquillised at endpoint of the study (Desired sedation/tranquillisation) · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Primary outcome: Failure to complete procedure (due to sedation‐related problems) · Adults (over 18 years) with requirement for an ERCP procedure with diagnostic intent
1 finding from 1 review
Incomplete procedure · adults requiring sedation before gastrointestinal endoscopy and bronchoscopy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Anterograde amnesia (defined by number of participants who recalled the procedure) · adults requiring sedation before gastrointestinal endoscopy and bronchoscopy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disinhibition or excitation · adults requiring sedation before gastrointestinal endoscopy and bronchoscopy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Discomfort/pain · adults requiring sedation before gastrointestinal endoscopy and bronchoscopy
1 finding from 1 review